Completed Infection & Immunity Genetics & Molecular Biology

Host determinants of disease outcomes in arboviral infections

In plain English

AI plain-English summary

Bluetongue virus kills some infected sheep and goats while leaving others with nothing more than a mild fever, and researchers want to know why. This matters because bluetongue is one of the most economically damaging viral diseases of livestock worldwide, and current control strategies—vaccines and insect control—are blunt tools that don't account for why some animals resist severe disease. The same puzzle applies to many other arboviruses, such as dengue or Zika, which also cause vastly different outcomes in different people. The researchers will infect animals and study cells in the lab to test whether the difference lies in how each host’s immune system balances viral replication with its own defences. If they can pinpoint the immune mechanisms that protect some animals, that knowledge could guide smarter vaccine design or breeding programmes for bluetongue. More broadly, it could provide a framework for understanding why some people get severely ill from mosquito-borne viruses while others do not—a question with no current answer.

View original technical description
Infections of animals or humans by viruses can result in many different clinical outcomes. Studying natural models of infection and disease can help us gain a full understanding of the mechanisms of viral pathogenesis, in the knowledge that this is influenced by virus-host co-evolution. In this proposal, we will study bluetongue, a vector-borne disease caused by bluetongue virus (BTV). Bluetongue is one of the major viral diseases of livestock. Essentially all domestic and wild ruminant are susceptible to BTV infection but the resulting clinical symptoms vary considerably (from mild fever to lethal haemorrhagic fever). In this proposal, we will address how a pathogenic virus renders some infected hosts seriously ill, whilst causing only mild/no disease in others, despite abundant viral replication in both. We will use in vitro and in vivo experiments to address our overarching hypothesis that the clinical fate of BTV infection is determined by the complex balance between virus replication in the face of the host’s innate and adaptive immune responses. The outcomes of this proposal will inform appropriate control strategies for this veterinary disease and generate an intellectual framework of value in understanding disease susceptibility in many other arboviral diseases of humans and animals.

View the original record at the funder ↗

Researchers

Massimo Palmarini (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Impact of T lymphocytes on clinical disease, immune responses and transmission of bluetongue virus in sheep
The RNA interactome necessary and sufficient for Orbivirus genome packaging
Expression and formulation of Bluetongue virus genes and proteins for development of effective vaccination strategies
Understanding the infection processes of Bluetongue virus as a model of complex, non-enveloped orbiviruses: viruses with segmented double-stranded RNA genomes and multilayered capsids.
Bluetongue virus changes the emission of volatile organic chemicals in the body odour of sheep and cattle during infection

Original classification

Investigator Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.